Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer
March 24, 2024
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
59% of This Vanguard ETF Is Invested in the "Magnificent Seven" Stocks. Is It a No-Brainer Buy Right Now?
March 24, 2024
If you want to own all of the Magnificent Seven stocks plus other megacap winners, this ETF could be right up your alley.
Via
The Motley Fool
Topics
ETFs
SPDR ETF Report For Friday, March 22
March 23, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Friday, March 22.
Via
Talk Markets
Topics
ETFs
Study Questions Serious Flaws in $35 Million Antidepressant Research
March 22, 2024
CCHR says millions of taxpayer dollars are wasted on psychotropic drug research later found to be flawed and harmful to consumersLOS ANGELES - March 22, 2024 - PRLog -- Researchers have reanalyzed data...
Via
PRLog
Topics
Fraud
Exposures
Legal
Product Safety
Hot Stocks: The 3 Best Opportunities for Investing in Weight Loss Drugs
March 22, 2024
The market for weight loss drug stocks is massive, and these three companies could be the biggest beneficiaries of this trend.
Via
InvestorPlace
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
March 22, 2024
Via
Benzinga
Eli Lilly and Co's Options Frenzy: What You Need to Know
March 20, 2024
Via
Benzinga
Don’t Sleep On Global Stocks
March 22, 2024
ESTX50 and DAX have kept up with SPX over the past three years and six months, even if NDX outpaces them nonetheless.
Via
Talk Markets
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
March 22, 2024
The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
Via
The Motley Fool
Did Eli Lilly Just One-Up Novo Nordisk?
March 22, 2024
Eli Lilly just partnered with Amazon to help accelerate distribution of its various treatments.
Via
The Motley Fool
Could Viking Therapeutics Become the Next Eli Lilly?
March 22, 2024
Viking shares have skyrocketed on its recent good news.
Via
The Motley Fool
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM
March 22, 2024
Via
Press Release Distribution Service
Topics
ETFs
Medicare Will Cover Weight-Loss Drugs — For Some. Here's What It Means For Novo, Lilly.
March 21, 2024
Novo Nordisk's Wegovy recently gained Food and Drug Administration approval to reduce the risk of cardiovascular problems.
Via
Investor's Business Daily
Wegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart Health
March 21, 2024
Medicare considers extending coverage for Novo Nordisk's Wegovy to eligible members with heart disease history. CMS may include anti-obesity drugs under certain Medicare Part D plans. Germany's health...
Via
Benzinga
Amazon’s 1-2 Punch: AI-Powered Listings and Eli Lilly Deal Make AMZN a Must-Buy
March 21, 2024
AMZN stock can easily continue to run higher as Amazon rolls out more AI features and works closely with a famous pharmaceutical giant.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions
March 20, 2024
Eli Lilly stock is up 32% so far in 2024 and has risen 318% over three years.
Via
Benzinga
Healthcare And Biotech Update With Market At 2024 Highs
March 20, 2024
The bull market is intact with technology Stocks dominating, but XLV is up 6.89%YTD.
Via
Talk Markets
Wall Street’s Favorite Tech Stocks? 3 Names That Could Make You Filthy Rich
March 20, 2024
Bet on success with Wall Street's favorite tech stocks. These investments have the potential to outperform the market.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 20, 2024
Via
Benzinga
Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?
March 20, 2024
The gap has been shrinking between these stocks over the past month.
Via
The Motley Fool
3 Stocks Ready to Ride the Bull Higher
March 20, 2024
Each of these securities is rising on strong earnings prints and catalysts that could send their share prices upwards in coming months.
Via
InvestorPlace
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
March 19, 2024
These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys.
Via
InvestorPlace
Visualizing The Biggest Companies On Major Stock Exchanges
March 19, 2024
The NYSE’s largest companies are more diversified, with a combination of tech, financial services, and healthcare names present.
Via
Talk Markets
What Retail Apocalypse? 7 Stocks Proving the Doomsayers Wrong.
March 19, 2024
People have said retail is dying for years now but the supposed apocalypse is nowhere to be found with these fast-charging retail stocks.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
Via
Benzinga
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
March 19, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter.
Via
Benzinga
Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover
March 19, 2024
The company is working on radiopharmaceuticals treatments for cancer.
Via
Investor's Business Daily
Did Novo Nordisk Just Get a Jump on Eli Lilly?
March 19, 2024
A recent FDA announcement may have just put one company in the lead.
Via
The Motley Fool
Exposures
Product Safety
AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments
March 19, 2024
AstraZeneca to acquire Fusion Pharmaceuticals for $21.00 per share cash plus $3.00 per share CVR upon regulatory milestone achievement, marking a significant $2.4 billion deal. Enhancing cancer...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.